DENTSPLY SIRONA XRAY Wellspect Healthcare — Adjusted selling expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DENTSPLY SIRONA in its filing.
Tagged under the XBRL concept xray:SellingExpenseAdjusted.
The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses?
- DENTSPLY SIRONA (XRAY) reported wellspect healthcare — adjusted selling expenses of $14M in Q1 2026.
- How has DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses changed year-over-year?
- DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses increased by 7.7% year-over-year, from $13M to $14M.
- What is the long-term trend for DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses?
- Over 3 years (2022 to 2025), DENTSPLY SIRONA's wellspect healthcare — adjusted selling expenses has grown at a 4.6% compound annual growth rate (CAGR), from $48M to $55M.
- What does wellspect healthcare — adjusted selling expenses mean?
- Captures the costs incurred by the Wellspect Healthcare segment for sales, marketing, and distribution activities to support product commercialization. This metric provides insight into the investment required to maintain or expand the segment's market share and customer base.